VERU INC. Operating Leases, Rent Expense
VERU INC. (VERU) reported Operating Leases, Rent Expense of $683.00 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2020-12-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-12-10
- VERU INC. operating leases, rent expense for fiscal 2019 was $683.00K, a 4.71% decline from fiscal 2018.
- VERU INC. operating leases, rent expense for fiscal 2018 was $716.78K, a 18.11% increase from fiscal 2017.
- VERU INC. operating leases, rent expense for fiscal 2017 was $606.89K, a 28.82% increase from fiscal 2016.
- VERU INC. operating leases, rent expense for fiscal 2016 was $471.13K, a 1.32% decline from fiscal 2015.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed | Operating Leases, Rent Expense 21 month |
|---|---|---|---|
| 2019-09-30 | $683.00K 10-K · filed 2020-12-10 | ||
| 2018-09-30 | $716.78K 10-K · filed 2018-12-13 | ||
| 2017-09-30 | $606.89K 10-K · filed 2018-12-13 | $505.30K 10-K · filed 2018-01-02 | |
| 2016-09-30 | $471.13K 10-K · filed 2018-01-02 | ||
| 2015-09-30 | $477.44K 10-K · filed 2018-01-02 | ||
| 2014-09-30 | $444.48K 10-K · filed 2016-12-12 | ||
| 2013-09-30 | $410.22K 10-K · filed 2015-12-02 | ||
| 2012-09-30 | $401.90K 10-K · filed 2014-12-02 | ||
| 2011-09-30 | $420.27K 10-K · filed 2013-12-03 | $420.27K 10-K · filed 2012-12-04 | |
| 2010-09-30 | $405.37K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |